Nov. 2, 2009 (China Knowledge) - Beijing Tiantan Biological Products Corp<600161>, which specializes in the development, production and sales of biopharmaceuticals, on Oct. 28 held a ground-breaking ceremony for its biological vaccine production base in Beijing Economic-Technological Development Area, or BDA.
Tiantan Biological will invest a total of RMB 2.66 billion in the base, which is c
.....